16 completed, 8 unknown, 3 recruiting, 3 withdrawn. 15 Not applicable, 6 Phase 2, 3 Phase 4, 2 Phase 1, 1 Phase 3.
Follow Olfactory Disorder: new trials by email Literature Review of Olfactory Disorder trials Research Report on Olfactory Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy of Olfactory Training Intervention on Olfactory and Other Non-motor Symptoms in PD Olfactory training - Parkinson Disease, Olfactory Disorder | Not applicable | Unknown | Anhui Medical University | 40 | 2024-09-25 | 2024-09-23 |
| Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID) Trigeminal Nerve Stimulation (TNS), Active Smell Training (ST), Placebo Smell Training (PBO) - Smell Dysfunction, Olfactory Disorder | Phase 2 / Phase 3 | Recruiting | Medical University of South Carolina | 145 | 2023-10-02 | 2026-04-02 |
| Olfactory Performance in Culinary Arts Students Olfactory training - Loss of Smell, Olfactory Disorder | Phase 4 | Unknown | Leigh Sowerby | 120 | 2023-09-25 | 2023-10-06 |
| Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia Simvastatin - Olfactory Disorder, COVID-19 | Phase 1 | Withdrawn | Washington University School of Medicine | 2023-05-01 | 2023-06-12 | |
| Sinus Disease in Young Children With Cystic Fibrosis Ivacaftor or elexacaftor/tezacaftor/ivacaftor - Cystic Fibrosis in Children, Cystic Fibrosis | Recruiting | University of California, Los Angeles | 80 | 2023-04-12 | 2026-09-10 | |
| Prospective Registery of Smell/Taste Clinic Ear/Nose/Throat Standard of care - Olfactory Disorder, Taste Disorders | Recruiting | Universitaire Ziekenhuizen KU Leuven | 500 | 2022-12-06 | 2025-12-18 | |
| Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction Stellate Ganglion Block - Anosmia, Hyposmia | Phase 1 / Phase 2 | Completed | Washington University School of Medicine | 20 | 2022-09-01 | 2026-02-12 |
| "Platelet Rich Plasma for the Management of Post-Viral Olfactory Dysfunction. Platelet rich plasma, Saline - Olfactory Disorder, Olfaction Disorders | Not applicable | Unknown | Thomas Jefferson University | 120 | 2022-08-17 | 2022-12-27 |
| The Efficacy of Traditional Chinese Medicine in Olfactory Dysfunction Traditional Chinese Medicine CU Xiu Tang, Olfactory Training - Olfactory Disorder | Not applicable | Unknown | Eye & ENT Hospital of Fudan University | 278 | 2022-07-15 | 2022-07-11 |
| Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction Gabapentin gelatin capsules 300mg, Placebo - COVID-19, Olfactory Disorder | Phase 2 | Completed | Washington University School of Medicine | 68 | 2022-01-10 | 2025-03-04 |
| Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia Fluvoxamine, Placebo - COVID-19, Olfactory Disorder | Phase 2 | Withdrawn | Washington University School of Medicine | 2021-12-14 | 2022-03-11 | |
| Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT] - Chronic Rhinosinusitis With Nasal Polyps, Olfactory Disorder | Phase 4 | Completed | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 15 | 2021-07-19 | 2026-09-22 |
| Intranasal Injection of PRP Versus Saline for Treatment of Olfactory Dysfunction Injection into olfactory cleft - Olfactory Disorder, Olfaction Disorders | Not applicable | Completed | Stanford University | 30 | 2021-06-22 | 2023-03-13 |
| Radiofrequency Intervention in Neurological Pathologies Post COVID-19 Radiofrequency therapy with manual therapy - Covid19, Neurological Injury | Not applicable | Completed | Clinica Gema Leon | 10 | 2021-06-16 | 2025-06-15 |
| Oral and Olfactory Complications of Recovered COVID-19 Patients Gustatory and olfactory function test, Molecular assessment of saliva - Oral Complication, Dysgeusia | Unknown | University of Giessen | 402 | 2021-05-01 | 2024-05-13 | |
| Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19) Essence oils - Covid19, SARS-CoV Infection | Not applicable | Unknown | Universidade do Estado do Pará | 350 | 2021-05-01 | 2021-02-21 |
| Smell in Covid-19 and Efficacy of Nasal Theophylline Theophylline Powder, Placebo Comparator - Covid19, Anosmia | Phase 2 | Completed | Washington University School of Medicine | 51 | 2021-03-15 | 2023-05-24 |
| Correlation of Preoperative Global Olfactory Function With Frailty, Perioperative Neurocognitive Disorders and Mortality Olfactory function testing, Edmonton Frail Scale, Clinical Frailty Scale - Frailty, Perioperative/Postoperative Complications | Not applicable | Completed | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 215 | 2021-03-01 | 2025-01-15 |
| Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19) Olfactory retraining, corticosteroid nasal irrigation, smell household Items - Olfactory Disorder | Phase 4 | Withdrawn | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2021-01-10 | 2025-08-01 | |
| The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function ENDS (vaporizer/e-cig) and smoking cessation counseling, Smoking cessation counseling - Smoking Cessation, Olfactory Disorder | Not applicable | Completed | University of Bern | 389 | 2020-09-07 | 2023-11-15 |
Showing 20 of 31. Sign in to see all of them.
Anosmia (17) · Olfaction Disorders (14) · COVID-19 (13) · Frailty (2) · Postoperative Complications (2) · Taste Disorders (2) · Acromegaly (1) · Ageusia (1) · Agnosia (1) · Brain Concussion (1) · Brain Injuries, Traumatic (1) · Cystic Fibrosis (1) · Disease (1) · Dysgeusia (1) · Fetal Growth Retardation (1)
Pathological Conditions, Signs and Symptoms (26) · Nervous System Diseases (25) · Neurologic Manifestations (24) · Signs and Symptoms (24) · Sensation Disorders (23) · Infections (14) · Lung Diseases (14) · Respiratory Tract Diseases (14) · Coronaviridae Infections (13) · Coronavirus Infections (13) · Nidovirales Infections (13) · Pneumonia (13) · Pneumonia, Viral (13) · RNA Virus Infections (13) · Respiratory Tract Infections (13)
Olfactory Training (6) · Sodium Chloride (2) · COVID-19 Serological Testing (1) · Fluvoxamine (1) · Mepivacaine (1) · Musculoskeletal Manipulations (1) · Nasal Lavage (1) · Oils, Volatile (1) · Radiofrequency Therapy (1) · Simvastatin (1) · Standard of Care (1) · Theophylline (1) · Transcutaneous Electric Nerve Stimulation (1) · Vitamin A (1) · dupilumab (1)
Washington University School of Medicine (7) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (2) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (2) · University of Kansas Medical Center (2) · Anhui Medical University (1) · Association "Naso Sano" Onlus (1) · Bezmialem Vakif University (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Clinica Gema Leon (1) · Eye & ENT Hospital of Fudan University (1) · Hospices Civils de Lyon (1) · Leigh Sowerby (1) · Medical University of South Carolina (1) · St. Paul's Hospital, Canada (1) · Stanford University (1)
United States (13) · Canada (4) · Belgium (3) · China (2) · Brazil (1) · France (1) · Germany (1) · Italy (1) · Spain (1) · Switzerland (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Jay F Piccirillo, MD (3) · Victoria Van Regemorter, MD (2) · Amin Javer, MD FRCSCFARS (1) · Daniel M Beswick, MD (1) · David Rosen, MD (1) · Donald D Beahm, MD (1) · Greg E Davis, MD, MPH (1) · Hongmeng Yu, Dr (1) · Jay F Piccirillo, M.D., FACS (1) · Jennifer Villwock, MD (1) · Leigh J Sowerby, MD, FRCS (1) · Leigh Sowerby, MD, FRCSC (1) · Nazan Degirmenci (1) · Nyssa F Farrell, MD (1)
PMID 32835303, PMID 32991844, PMID 33386970, PMID 33497610, PMID 33937733, PMID 35797024, PMID 36507615, PMID 37648990, PMID 37733356, PMID 39811548, PMID 41424768
2017 (1), R01DC021179 (1)